Objective: To conduct clinical, genetic, and molecular diagnostics of two sisters with typical symptoms of complete androgen insensitivity syndrome. Design: Case report. Setting: Research laboratory at a university of...Objective: To conduct clinical, genetic, and molecular diagnostics of two sisters with typical symptoms of complete androgen insensitivity syndrome. Design: Case report. Setting: Research laboratory at a university of medical science. Patient(s): Two patients with 46,XY karyotype and a female phenotype were diagnosed because of primary amenorrhea. Their sister with 46,XX karyotype, her daughter, and five other family members including their mother also were examined. Intervention(s): Orchiectomy, estrogen substitution therapy. Main Outcome Measure(s): Cancer prophylaxis. Result(s): Multiple-temperature single-stranded conformation polymorphism and sequence analyses of the androgen receptor gene(AR) revealed a c.C2812T transition in exon 7 in the two sisters. Their mother and the third sister(46,XX) were carriers of the same mutation. This mutation, which previously had never been reported, resulted in Pro817Leu substitution in the ligand-binding domain of the androgen. Computer simulation of structural changes generated by Pro817Leu substitution revealed appreciable conformational changes in the region responsible for dimerization of the receptor. Conclusion(s): The novel c.C2812T transition that might impair dimerization of the receptor is responsible for the clinical symptoms of complete androgen insensitivity syndrome in the affected individuals. Molecular analysis of AR proved to be very useful for genetic counseling of the unaffected sister, who was a carrier of the same mutation.展开更多
文摘Objective: To conduct clinical, genetic, and molecular diagnostics of two sisters with typical symptoms of complete androgen insensitivity syndrome. Design: Case report. Setting: Research laboratory at a university of medical science. Patient(s): Two patients with 46,XY karyotype and a female phenotype were diagnosed because of primary amenorrhea. Their sister with 46,XX karyotype, her daughter, and five other family members including their mother also were examined. Intervention(s): Orchiectomy, estrogen substitution therapy. Main Outcome Measure(s): Cancer prophylaxis. Result(s): Multiple-temperature single-stranded conformation polymorphism and sequence analyses of the androgen receptor gene(AR) revealed a c.C2812T transition in exon 7 in the two sisters. Their mother and the third sister(46,XX) were carriers of the same mutation. This mutation, which previously had never been reported, resulted in Pro817Leu substitution in the ligand-binding domain of the androgen. Computer simulation of structural changes generated by Pro817Leu substitution revealed appreciable conformational changes in the region responsible for dimerization of the receptor. Conclusion(s): The novel c.C2812T transition that might impair dimerization of the receptor is responsible for the clinical symptoms of complete androgen insensitivity syndrome in the affected individuals. Molecular analysis of AR proved to be very useful for genetic counseling of the unaffected sister, who was a carrier of the same mutation.
